The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15).
 
Jieun Lee
No Relationships to Disclose
 
Dae-Won Lee
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boryung Pharmaceuticals (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Min Hwan Kim
No Relationships to Disclose
 
Jee Hung Kim
No Relationships to Disclose
 
Kyong Hwa Park
Stock and Other Ownership Interests - iMBDx
Honoraria - Celltrion
Consulting or Advisory Role - AstraZeneca; Daichi Sankyo
Patents, Royalties, Other Intellectual Property - IP transfer fee
Expert Testimony - LegoChem Biosciences
 
Jae Ho Byun
No Relationships to Disclose
 
Kyoung Eun Lee
No Relationships to Disclose
 
Myoung Joo Kang
No Relationships to Disclose
 
Su-Jin Koh
No Relationships to Disclose
 
Soojung Hong
No Relationships to Disclose
 
Hye Sung Won
No Relationships to Disclose
 
Han Jo Kim
No Relationships to Disclose
 
In Hae Park
No Relationships to Disclose
 
Seong Hoon Shin
No Relationships to Disclose
 
Sun Kyung Baek
No Relationships to Disclose
 
Seul-Gi Kim
No Relationships to Disclose
 
Sung Ae Koh
No Relationships to Disclose
 
Joo Young Jung
No Relationships to Disclose
 
Yeon Hee Park
Honoraria - AstraZeneca; Daiichi-Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boryung; Daiichi-Sankyo; Eisai; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Gencurix (Inst); Genome Insight (Inst); NGeneBio (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Gilad